NLRP3 and multiple sclerosis: On the contrary, dysregulation of NLRP3 inflammasome activation has been implicated in various inflammatory diseases, such as neurologic disorders (multiple sclerosis, Alzheimer's disease, and Parkinson's disease) and metabolic diseases (type 2 diabetes, obesity, gouty arthritis and atherosclerosis), in addition to infectious diseases (4).